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ABSTRACT
Introduction: We designed a prospective observational study targeting a selective population of patients undergoing elective coronary artery bypass grafting with normal systolic function. In this study we looked at the
prevalence of pre-operative microvolt T-wave alternans and if it predicts atrial fibrillation after surgery.
Methods: The inclusion criteria included all patients referred to the cardiothoracic outpatient clinic for elective bypass, who can perform aerobic exercise, with a recent exercise stress test exercising at least to 85% of the
maximal predicted heart rate (220 - age) and with non-limiting chest pain at maximal exercise. Twenty patients
met the inclusion/exclusion criteria between May 2008 and February 2010. The hospital course of those patients was followed, and in-hospital events were recorded.
Results: Nine out twenty (45%) of patients had a non-negative microvolt T-wave alternans tracing. Six patients
(30%) developed new onset atrial fibrillation post surgery. Patients with non-negative microvolt level T-wave
alternans are more likely to develop atrial fibrillation post coronary artery bypass grafting then patients with
negative microvolt level T-wave alternans (p=0.05).
Conclusions: This pilot study provides the first clinical evidence that patients with ischemic heart disease and
normal systolic function have a high prevalence of abnormal microvolt T-wave alternans and might be at higher
risk of sudden cardiac death. In addition our results show that microvolt level T-wave alternans predicts post
coronary artery bypass grafting new onset atrial fibrillation.
Keywords: microvolt T, wave alternans, atrial fibrillation, sudden cardiac death.

INTRODUCTION
T-wave alternans is characterized by beatto-beat change in the morphology, amplitude and/or polarity of the T wave. Microvolt level T-wave alternans (MTWA) has
been proposed to assess the abnormalities
in ventricular repolarization, which favors
the occurrence of reentrant arrhythmias
(1). In 1994, a first clinical study by RosenCorresponding author:
Georges Khoueiry, M.D.
Staten Island University Hospital
475 Seaview Avenue
Staten Island, NY 10305

baum and coworkers demonstrated that
MTWA is closely related to arrhythmia induction in the electrophysiology laboratory
as well as to the occurrence of spontaneous ventricular tachyarrhythmias during
follow-up (2, 3). Microvolt TWA analysis
has been implicated as one of the strongest predictors of ventricular arrhythmias
and sudden cardiac death (also superior to
other non-invasive markers of ventricular
repolarization, such as QTc interval prolongation) in several trials including patients
with myocardial infarction, heart failure
and implantable defibrillators (3 -5). Two
main hypotheses have been proposed for
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the mechanism of MTWA, the action potential restitution and the calcium cycling
hypothesis. There is considerable experimental and clinical trials that do not support the restitution hypothesis (6, 7) on the
other hand there is considerable evidence
to support the abnormal calcium cycling
hypothesi (8).
Patients undergoing elective coronary artery bypass grafting (CABG) tend to be
relatively healthy and subsequently their
surgery is significantly delayed when compared to urgent cases. The cumulative presurgical risk of death from cardiovascular
disease was found to be similar in the semiurgent and elective CABG cases due to the
longer wait for surgery in the later group
(9). The in-hospital death was also shown
to be significantly higher when the surgery
is delayed beyond the recommended time
of 12 weeks in non-urgent cases (10). However there is no data that reports on the risk
of sudden cardiac death in elective CABG
patients with no structural heart disease.
Also, none of the studies looked at the prevalence of MTWA as a predictor of sudden
cardiac death (SCD) in this population.
Also, in patients undergoing CABG, new
onset post operative atrial fibrillation (Afib)
is a very common complication (11). Patient
with this complication were found to have
a significant higher mortality at 10 years of
follow up (11). Recently Afib was linked to
abnormal calcium handling, a mechanism
proposed for abnormal MTWA tracing (12,
13). Although MTWA and Afib may share
a similar underlying mechanism, there are
no reports on the risk of new onset Afib in
patients with abnormal T wave alternans
testing.
We designed a prospective observational
study targeting a selective population of
patients undergoing elective CABG with
normal systolic function. In this study
we looked at the prevalence of pre-operative MTWA. We followed these patients

throughout their hospital stay and looked
at the incidence of new onset Afib in patients with normal and abnormal MTWA
tracing.
METHODS
This study was conducted at a 700 bed University Affiliated urban teaching hospital. It
is an observational study. The institutional
review boards approved the study protocol.
All patients signed an informed consent after a detailed explanation of the study aim
and purpose. The inclusion criteria included all patients referred to the cardiothoracic
outpatient clinic for elective CABG, who
can perform aerobic exercise, and agree to
have a MTWA testing prior to the scheduled surgery. Since MTWA testing involves
a submaximal treadmill exercise test, and
our population involves patients with significant coronary artery disease (CAD), we
pre-specified a safety measure in our protocol. We only considered patients with a
recent exercise stress test who reached at
least 85% of the maximal predicted heart
rate (220 - age) and non-limiting chest pain
at maximal exercise. The exclusion criteria included any of the following criteria;
age less than 18, pregnancy, left ventricular ejection fraction (LVEF) less than 50%,
Patients on any antiarrhytmic medications,
baseline electrolyte abnormalities, known
history of atrial fibrillation, stage 5 chronic
kidney disease (CKD), and inability to perform a submaximal treadmill test.
The patients were recruited between May
2008 and February 2010 at an outpatient
cardiothoracic office at Staten Island University Hospital. In this study we used the
Heartwave System (Cambridge Heart Inc.,
Cambridge, MA, USA). HearTwave® II System detects the presence of MTWA By electrocardiogram (EKG) measurements during
rest, exercise, and then rest again. Fourteen
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sensors - 7 Micro-V Alternans Sensors and
7 standard electrodes - are placed in the
Frank-lead configuration. The electrodes
are connected to the digital EKG amplifier
that leads back to the MTWA enabled system.
After checking the system for correct lead
placement, the patient is directed to begin
walking on a treadmill to raise the heart
rate. The exercise part consists of two levels. The first aims to maintain the heart
rate at 100-110 bpm for a total 90 seconds,
while the second goal is to achieve a heart
rate of 110-120 for the same time interval.
The total time of submaximal exercise can
range between 5-10 minutes to achieve and
adequate recording. The patients were instructed to hold calcium channel blockers
or beta-blockers on the day of testing to
achieve adequate heart rate with minimal
exercise.
Based on the previously defined criteria
by Bloomfield et al., MTWA tracing was
interpreted as either negative or non-negative which included patient with positive
or intermediate tracing (14). Studies have
well shown that intermediate and positive
MTWA tracing, have similar prognostic
value (15, 16). Each test was analyzed by
the same electrophysiologist (cardiologist),

and confirmed by a trained technician from
the company, who was blinded to the study
and patients.
The hospital course of all patients included
in the study was followed, and in-hospital
events were recorded. This included, post
surgery Afib, sustained ventricular tachycardia, ventricular fibrillation, cardiac arrest, arrhythmias requiring anti-arrhythmic
treatment, and hospital death.
In order to assess the prevalence of atrial
fibrillation in patients with a non-negative
MTWA we divided the sample into two
groups. The first involved all patients with
non-negative test MTWA (+), while the
second included all with a negative test
MTWA (-). We also studied variables that
were shown to predict atrial fibrillation post
CABG. Based on a study done by Amar et.
al, 4 variables were shown to predict Afib
post CABG. These included older age, prior
history of Afib, P-wave duration >110 ms
on surface EKG, and low cardiac output defined as cardiac index <2 l/min/m2 for >
8 h after surgery (17). In that study a point
score was developed to predict the probability of post CABG Afib. In our study we used
this validated score to compare the risk of
post-CABG Afib in the MTWA groups (Table 1).

Table 1 - Clinical characteristic and outcome by Microvolt T-wave Alternans (MTWA) groups.

History of MI

MTWA (+) test
(n=9)

MTWA (-) test
(n=11)

p-value

1 (11%)

3 (27%)

0.4

History of DM

3 (33%)

4 (36%)

1.0

GFR (ml/min/m2)

75* (35-105)**

90* (43-115)**

0.1

Ejection fraction (%)

58* (50-70)**

58* (55-65)**

0.8

Post CABG Afib

5 (55%)

1 (9%)

0.05

Point score

68* (50-80)

64* (45-80)**

0.3

1 (11%)

0 (0%)

0.4

for risk of post CABG Afib
Post CABG cardiac arrest

*Mean, **Range
MTWA = Microvolt level T-wave alternans; MI = myocardial infarction; DM = diabetes mellitus; GFR = glomerular filtration rate; CABG = coronary artery bypass graft; Afib = atrial fibrillation.
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Statistical analysis. Continuous variables
were expressed as a mean ± standard deviation (SD) and were compared using an
unpaired two-tailed Student’s t-test.
Unpaired categorical variables were compared using Fisher’s exact test. A probability cutoff of p<0.05 was considered significant for all statistical determinations.
A multivariate logistic regression model was
used to evaluate the independent contribution of baseline clinical characteristics to the
development of the end point in a forward
stepwise manner.
At each step, a significance of 0.10 was required to enter into the model while those
with probabilities less than 0.05 were considered statistically significant. All analyses were performed using SPSS 19.0 (SPSS
Inc., Chicago, IL).
RESULTS
Sixty three patients were initially considered for enrollment. Only 36 met the inclusion criteria that were specified in our
study protocol. Out of those, twenty four
consented and were further followed. Of
the 24 patients, 4 did not show up on the
day of the MTWA testing and were dropped
out of the study. The characteristics of the
studied sample population are listed in Table 2. The mean age was 62.3±10.97 years.
The majority were male (90%), and white
(75%). Hypertension and hyperlipidemia
were highly prevalent (90%). The average
number of bypassed vessels was 3.5.
The median and mean time elapse from coronary angiography to bypass surgery was
29 and 23 days, respectively. All MTWA
tests were performed within a week prior
to the scheduled surgery. The results are
shown in Table 1. Nine out twenty (45%)
patients had a non-negative MTWA tracing. The mean age of MTWA (+) group
was 64 years slightly older than the MTWA

Table 2 - Demographics and hospital events.
Demographics
Sex

Count

Percent

Male

18

90%

Female

2

10%

White

15

75%

All Other

5

25%

Hypertension

18

90%

History of dysrhythmias

0

0%

Diabetes Mellitus

7

35%

Hyperlipidemia

18

90%

Myocardial Infarction

4

20%

History of atrial fibrillation

0

0%

Beta Blocker

16

80%

Aspirin

18

90%

Clopidogrel

12

60%

ACE/ARB

13

65%

CCB

4

20%

13

65%

Cerebrovascular Accident

0

0%

Atrial Fibrillation

6

30%

Myocardial Infarction

0

0%

Asystole

1

5%

Race

Past Medical History

Medications

Social History
Smoking
Post Surgical Complications

ACE = angiotensin converting enzyme inhibitor; ARB =
angiotensin receptor blocker; CCB = calcium channel blocker.

(-) group which was 61years. Diabetes mellitus (DM) and prior history of myocardial
infarction (MI) was slightly higher in the
MTWA (-) group. The mean glomerular filtration rate was lower in the MTWA (+),
but none of the patients had a stage 5 CKD,
as this was one of the exclusion criteria.
The Point score that predicts the risk of
post CABG Afib was similar in both groups
(Table 1).
All patients were followed throughout the
hospital course. The mean hospital stay
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Figure 1 - The incidence of postcoronary artery bypass graft
atrial fibrillation by Microvolt
T-wave Alternans (MTWA)
groups.
AF =atrial fibrillation.

was 4 and 7 days among MTWA (-) and
MTWA (+) groups, respectively. The
hospital stay did not differ between the 2
groups. There was no in-hospital death.
One patient in the MTWA (+) group
had a cardiac arrest post surgery and was
successfully resuscitated. There were no
events of sustained ventricular tachycardia
or ventricular fibrillation in both groups.
One (9%) patient with negative MTWA
developed AF in comparision to 5 (55%)
paitens with non-negative MTWA. Patients
with non-negative MTWA are more likely
to develop AF post CABG then patiens with
negative MTWA (p=0.05) (Table 1, Figure
1). In multivarient logistic regresion, a nonnegative MTWA was the only predictor of
AF (p=0.042). Two patients with Afib required electrical cardioversion, while the
others were converted chemically.
Finally we looked at the 30 months mortality using the national death registry. There
was no reported death in any of the groups.
DISCUSSION
In MADIT-2 trial MTWA was shown to
have a better risk stratification for SCD

when compared to QRS duration on EKG
in patients with ischemic heart disease
(18). In several studies, MTWA was shown
to have a prognostic value after acute myocardial infarction (19, 20).
In our study we found that the prevalence
of abnormal MTWA is very high when compared to previous reports on healthy adults.
In this study we aimed to assess the prevalence of abnormal cardiac repolarization in
patients with ischemic heart disease scheduled for elective CABG. All of our patients
had a systolic function of more than 50%,
and none of them had a significant CKD as
we specified in our study protocol (Table
1). The reported prevalence of abnormal
MTWA in healthy adults ranged between 4
and 5% (21, 22). Post MI it was reported to
be abnormal in up to 44% of patients (20).
Abnormal MTWA was also reported to be
high in diabetics, in patients with uremic
cardiomyopathies, and in patients on hemodialysis (23-27). Neither ischemic, nor
uremic cardiomyopathy can explain the
high prevalence of abnormal MTWA in our
studied population (45%). Moreover, looking at other potential clinical predictors for
abnormal MTWA, there was more patients
with history of DM and prior MI in the
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MTWA (-) group. In the MTWA (+) group,
one patient had history of MI, and 3 had
DM. None of those patients had a concomitant history of MI and DM. On the other
hand in the MTWA (-) group, three had a
prior history of MI, and 4 where diabetic.
Of those, two had DM and MI. There was
no statistically significant difference in any
of the known clinical predictors of abnormal MTWA in both groups (Table 1). For
this reason, although DM and prior history
of MI could have contributed to the MTWA
test results in this population, it does not
exclusively explain the high prevalence noted in our population.
Animal studies have shown that regional
myocardial ischemia in structurally normal
hearts can lead to regional action potential
alternans (28, 29). This can lead electrical
dispersion and arrhythmias (29). Regional
Ischemia induced by exercise might explain
the prevalence of abnormal MTWA in this
population. There are no previous studies
that looked at MTWA as a predictor of SCD
in patients with ischemia but normal systolic function. One patient with abnormal
MTWA tracing had a post surgical asystole,
and was successfully resuscitated. There
was no recorded death in both groups at 30
months of follow up.
Although our observation may suggest that
patients awaiting elective CABG are at high
risk of arrhythmias and SCD, Further studies are needed to assess the potential risk
in this population before drawing further
conclusion.
The incidence on new onset atrial fibrillation post CABG varies between 11% and
40% depending on the study cohort and
method of detection used (11, 30). In this
study we excluded patients with history of
Afib. Post-op, 30% of patients developed
new onset atrial fibrillation. Interestingly,
most of those had an abnormal MTWA
tracing. Patients with non-negative MTWA
are more likely to develop atrial fibrillation

(AF) post CABG then patiens with negative
MTWA with a significant p value (p=0.05)
(Table 1, Figure 1). In multivarient logistic
regresion, a non-negative MTWA was the
only predictor of AF (p=0.042).
There is growing evidence that links atrial
fibrillation to abnormal calcium handling/
calcium alterans (12, 13). Similarly, there
are considerable evidence that abnormal
calcium cycling/calcium alternans is the
mechanism behind action potential and T
wave alternans. Since MTWA tracing in patients with atrial fibrillation is not feasible,
no studies have looked at the prevalence
of abnormal MTWA in patient with Afib.
Also there no previous reports on the risk
of new onset Afib in patients with abnormal T wave alternans testing. Knowing that
both Afib and abnormal MTWA might have
a common electrical mechanism, this study
presents the first direct link between the
two. We think that the risk of post-CABG
atrial fibrillation might be further stratified
by pre-CABG MTWA in groups with comparable other risk scores. Although this
finding is very interesting we only suggest
a potential association between abnormal
MTWA and Afib, and further studies with
more patients are needed to consolidate our
finding.
There are several limitations to this study.
The sample size is small and limits us from
generalizing our results. Although this is
a significant limitation we think that our
results are very interesting to report especially that we targeted a very specific group
of patients.
We had many exclusion criteria to assure
patient safety, which limited our ability to
recruit a larger sample. A multicenter study
will be needed to recruit a larger and more
representative sample. Another limitation
is that the prognosis of abnormal MTWA
testing is not well established in patients
with ischemic heart disease with normal
systolic function. For this reason even with
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this high prevalence of abnormal MTWA
results, the risk of SCD is still unknown.
Furthermore, there was no difference in
mortality at any interval follow up in both
groups. For this reason no assumption can
be drawn on the risk of SCD in this population until we have more data.

10.

11.

12.

CONCLUSION
13.

This pilot study provides the first clinical
evidence that patients with ischemic heart
disease and normal systolic function have
a high prevalence of abnormal MTWA and
might be at higher risk of SCD.
In addition our results shows that MTWA
predicts post CABG new onset atrial fibrillation. MTWA might be studied as a potential factor in future Afib risk scores. Despite
our interesting findings, we suggest a multicenter study with a larger representative
sample to confirm our findings.

14.
15.

16.
17.

18.
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